Unlocking GLP 1: A Visual Guide to Understanding Its Mechanism Through Engaging Graphics, Pictures, and Informative Charts.
How GLP

Body System Effects Map Semaglutide and tirzepatide work through GLP-1 receptors found throughout the body. This visual guide shows how each system benefits from treatment.

GLP-1s are generally well tolerated, with most gastrointestinal side effects subsiding over time. If you have additional questions on GLP-1 medications or just want more information on diabetes or weight loss treatment in general you can connect with a licensed pharmacist on-demand using Medidex Connect. References Min T, Bain SC.
PDF infographic

2 1 3 In people with type 2 diabetes, other body parts like the liver and the gut can be affected by how GLP-1 and the pancreas work together to manage blood glucose.
Researchers are starting to uncover how GLP-1 receptor agonists work for diabetes, weight loss, and other potential diseases.

Visual representation of the mechanism of action of glucagon
Download scientific diagram | Visual representation of the mechanism of action of glucagon-like peptide 1 ( GLP-1 ), as well as GLP-1 agonists and dipeptidyl peptidase-4 (DDP-4) inhibitors. * The ...
How do GLP-1 medications work ? We'll use 3D visuals from Visible Body to help illustrate how these drugs help with diabetes management and weight loss.

How GLP
THE BOTTOM LINE What they are: GLP-1 receptor agonists are medications that mimic a natural incretin hormone your gut releases after you eat, called glucagon-like peptide-1 ( GLP-1 ). 1 How they work for blood sugar: They help your pancreas release insulin only when blood sugar is high and block a hormone that raises blood sugar.
GLP-1 was discovered in 1987, and since then, its significance has been recognized in diabetes treatment and weight management. Understanding its history provides insight into its evolving research and applications. GLP-1 is an incretin hormone secreted by the intestinal L cells in response to food intake, primarily glucose.

Role of GLP1 in different body organs. This shows the physiological ...
This shows the physiological effects of GLP‐1 on different organs and peripheral tissues. They act on pancreatic islets β cells to increase glucose‐dependent insulin release and on pancreatic ...









Illustration of an inactivated glucagon-like peptide-1 ( GLP-1 ) receptor (blue, left) surrounded by semaglutide molecules (red) and activated GLP-1 receptor (right) binding to a semaglutide agonist. Semaglutide is a GLP-1 receptor agonist, a type of drug that mimics the function of natural GLP-1 hormones.